Riskpilot← Back to searchSign inGet full accessDRSK Group AB
ABActiveOrg 5568800345Enhörningsvägen 6 CManufacture of medical and dental instruments and supplies · NACE 3250Est. 20125-9 employees
Revenue 2024
SEK 3,5M
-20% vs 2023
EBITDA margin
6.9%
-65% vs 2023
Equity ratio
21.1%
Financial strength
Net profit 2024
SEK 50K
-86% vs 2023
| Revenue | SEK 3,5M | -20% |
| EBITDA | SEK 243K | -65% |
| Net profit | SEK 50K | -86% |
| Total assets | SEK 2,7M | -3% |
| Equity | SEK 574K | +9% |
| Employees | — | — |
Legal name
DRSK Group AB
Org number
5568800345
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
9 januari 2012
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Hasanzade Eishabadi, Nazila Kazemi, Mohammadreza Kazemi, Saeid
Company purpose
Bolaget skall bedriva tillverkning, import och export av dentala produkter samt därmed förenlig verksamhet. Dessutom bedriva konsultverksamhet inom datateknik.
Address
Enhörningsvägen 6 C
Phone
+46451762032
Email
drsk@drsk.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 103 | 1 869 | 2 613 | 4 370 | 3 514 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 612 | 266 | 248 | 699 | 243 |
| Depreciation & amort. | −131 | −143 | −136 | −197 | −193 |
| EBIT | 481 | 123 | 112 | 502 | 50 |
| Net financials | −12 | −10 | 9 | −50 | 16 |
| Profit before tax | 469 | 113 | 51 | 463 | 63 |
| Tax | −0 | −12 | −11 | −95 | −13 |
| Net profit | 469 | 101 | 40 | 368 | 50 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 818 | 2 144 | 2 070 | 2 812 | 2 715 |
| Equity | 216 | 117 | 157 | 525 | 574 |
| Long-term debt | 1 558 | 1 681 | 1 495 | 884 | 833 |
| Short-term debt | 45 | 347 | 347 | 1 343 | 1 244 |
| Total debt | 1 603 | 2 028 | 1 842 | 2 227 | 2 077 |
EBITDA margin
6.9%
This company
15.8%
Market median
-56% vs market
20202024
Equity ratio
21.1%
This company
38.2%
Market median
-45% vs market
20202024
Return on equity
8.7%
This company
18.4%
Market median
-53% vs market
20202024
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
20202024
Asset turnover
1.29×
This company
1.12×
Market median
+15% vs market
20202024
Debt / equity
3.73×
This company
0.62×
Market median
-502% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LA | Audit | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DRSK Group AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Anton Charles Nyström | Audit | 0 companies |
| Mohammadreza Kazemi | Board of Directors | 0 companies |
| Nazila Hasanzade Eishabadi | Deputy Board Member | 0 companies |
| Mohammadali Samet | Board of Directors | 0 companies |
| Saeid Kazemi | Chairman | 0 companies |